Immunocore Holdings's total assets for Q3 2025 were £1.10B, an increase of 1.86% from the previous quarter. IMCR total liabilities were £705.94M for the fiscal quarter, a 1.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.